Decibel Therapeutics (DBTX) Filings

15-12G

Securities registration termination

10 Oct 23

EFFECT

Notice of effectiveness

6 Oct 23

S-8 POS

Registration of securities for employees (post-effective amendment)

25 Sep 23

S-8 POS

Registration of securities for employees (post-effective amendment)

25 Sep 23

S-8 POS

Registration of securities for employees (post-effective amendment)

25 Sep 23

POS AM

Prospectus update (post-effective amendment)

25 Sep 23

8-K

Completion of Acquisition or Disposition of Assets

25 Sep 23

SC 14D9/A

Tender offer solicitation (amended)

25 Sep 23

25-NSE

Exchange delisting

25 Sep 23

SC TO-T/A

Third party tender offer statement (amended)

25 Sep 23

SC TO-T/A

Third party tender offer statement (amended)

12 Sep 23

SC 14D9/A

Tender offer solicitation (amended)

12 Sep 23

SC 14D9/A

Tender offer solicitation (amended)

8 Sep 23

SC TO-T/A

Third party tender offer statement (amended)

8 Sep 23

SC 14D9

Tender offer solicitation

25 Aug 23

SC TO-T

Third party tender offer statement

25 Aug 23

8-K

Other Events

25 Aug 23

SC14D9C

Written communication relating to third party tender offer

9 Aug 23

SC TO-C

Information about tender offer

9 Aug 23

8-K

Tender and Support Agreement

9 Aug 23

8-K

Submission of Matters to a Vote of Security Holders

13 Jun 23

ARS

2022 FY

Annual report to shareholders

28 Apr 23

DEFA14A

Additional proxy soliciting materials

28 Apr 23

PRE 14A

Preliminary proxy

14 Apr 23

8-K

Amendments to Articles of Incorporation or Bylaws

6 Apr 23

8-K

Departure of Directors or Certain Officers

21 Mar 23

S-8

Registration of securities for employees

14 Mar 23

8-K

Regulation FD Disclosure

10 Mar 23

8-K

Regulation FD Disclosure

9 Jan 23

8-K

Other Events

17 Oct 22

8-K

Departure of Directors or Certain Officers

12 Oct 22

8-K

Other Events

20 Sep 22

8-K

Departure of Directors or Certain Officers

13 Sep 22

8-K

Other Events

10 Aug 22

424B5

Prospectus supplement for primary offering

10 Aug 22

SC 13G/A

CITADEL ADVISORS LLC

14 Feb 24

SC 13D/A

REGENERON PHARMACEUTICALS, INC.

27 Sep 23

4

Anna Trask

25 Sep 23

4

William H. Carson

25 Sep 23

4

John Jui-Jen Lee

25 Sep 23

4

ALISON CECILY FINGER

25 Sep 23

4

KEVIN F MCLAUGHLIN

25 Sep 23

4

Laurence Reid

25 Sep 23

4

Matthew C Kapusta

25 Sep 23

4

Sara Nochur

25 Sep 23

SC 13D

REGENERON PHARMACEUTICALS, INC.

18 Aug 23

4

Sara Nochur

14 Jun 23

4

William H. Carson

14 Jun 23

4

ALISON CECILY FINGER

14 Jun 23

4

KEVIN F MCLAUGHLIN

14 Jun 23

4

Matthew C Kapusta

21 Mar 23

3

Matthew C Kapusta

21 Mar 23

4

Laurence Reid

17 Mar 23

SC 13G/A

CITADEL ADVISORS LLC

14 Feb 23

SC 13G

BlackRock Inc.

3 Feb 23

4

Anna Trask

30 Jan 23

4

John Jui-Jen Lee

30 Jan 23

3

JAMES B MURPHY

12 Oct 22

4

KEVIN F MCLAUGHLIN

12 Oct 22

3

KEVIN F MCLAUGHLIN

12 Oct 22

4

ALISON CECILY FINGER

21 Jun 22

4

William H. Carson

21 Jun 22

4

Peter A. Thompson

21 Jun 22

4

Sara Nochur

21 Jun 22

4

Neil Exter

21 Jun 22

4

Anna Trask

28 Feb 22

4

John Jui-Jen Lee

28 Feb 22

4

Laurence Reid

28 Feb 22

4

Elisabeth Leiderman

28 Feb 22

SC 13G

GV 2016, L.P.

14 Feb 22

SC 13G/A

CITADEL ADVISORS LLC

14 Feb 22

SC 13G

Third Rock Ventures III, L.P.

14 Feb 22

SC 13G

REGENERON PHARMACEUTICALS, INC.

11 Feb 22

4

Anna Trask

4 Jan 22

4

Anna Trask

6 Dec 21